LAVA Therapeutics NV - N51517105
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Chief Financial Officer | D | D | 124,700.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | Chief Financial Officer | D | D | 65,000.0 | — | — | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 10,000.0 | — | — | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 33,390.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | D | D | 30,000.0 | — | — | 0.0 | View | |
| Nov 17, 2025 | Chief Executive Officer | D | D | 335,100.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | Chief Executive Officer | D | D | 5,000.0 | — | — | 0.0 | View |